Objective: To determine the impact of low-dose aspirin (81 mg) on markers of maternal inflammation and placental function.
Setting: Rural Southern India.
Population: Nulliparous women with a singleton pregnancy dated by ultrasound who were enrolled in the ASPIRIN (Aspirin Supplementation for Pregnancy Indicated risk Reduction In Nulliparas) Trial.